What is the market capitalization of Femasys Inc.?

Femasys Inc. (FEMY) has a market capitalization of approximately 22,229,812 USD.

How many ETFs hold FEMY?

FEMY is held by 1 ETFs tracked on Investir en Bourse.

Where can I buy FEMY in Canada?

FEMY can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

FEMY

Femasys Inc.

Femasys Inc. (FEMY) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 22 million USD (micro-cap).

Details

Price0.37 USD

Market cap22.23 M USD

Payout ratio0.00%

ROE-455.80%

Debt / Equity80.03%

SectorHealthcare

Websitefemasys.com

Updated 1h ago

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.